These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29998869)

  • 1. Oxidative stress as a possible pathogenic cofactor of post-menopausal osteoporosis: Existing evidence in support of the axis oestrogen deficiency-redox imbalance-bone loss.
    Bonaccorsi G; Piva I; Greco P; Cervellati C
    Indian J Med Res; 2018 Apr; 147(4):341-351. PubMed ID: 29998869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Oxidative Stress and Inflammation Mediators of Bone Loss Due to Estrogen Deficiency? A Review of Current Evidence.
    Mohamad NV; Ima-Nirwana S; Chin KY
    Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1478-1487. PubMed ID: 32496996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mass density selectively correlates with serum markers of oxidative damage in post-menopausal women.
    Cervellati C; Bonaccorsi G; Cremonini E; Bergamini CM; Patella A; Castaldini C; Ferrazzini S; Capatti A; Picarelli V; Pansini FS; Massari L
    Clin Chem Lab Med; 2013 Feb; 51(2):333-8. PubMed ID: 23089610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle redox disturbances and oxidative stress as pathomechanisms and therapeutic targets in early-onset myopathies.
    Moulin M; Ferreiro A
    Semin Cell Dev Biol; 2017 Apr; 64():213-223. PubMed ID: 27531051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative damage and the pathogenesis of menopause related disturbances and diseases.
    Cervellati C; Bergamini CM
    Clin Chem Lab Med; 2016 May; 54(5):739-53. PubMed ID: 26544103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
    Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT).
    Hadji P; Gottschalk M; Ziller V; Kalder M; Jackisch C; Wagner U
    Maturitas; 2007 Mar; 56(3):312-21. PubMed ID: 17049767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia.
    Cervellati C; Romani A; Cremonini E; Bergamini CM; Fila E; Squerzanti M; Greco P; Massari L; Bonaccorsi G
    Oxid Med Cell Longev; 2016; 2016():6038798. PubMed ID: 26635910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis.
    Hernandez CJ; Beaupré GS; Carter DR
    Osteoporos Int; 2003 Oct; 14(10):843-7. PubMed ID: 12904837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of oestrogen deficiency on the skeleton and its prevention.
    Fogelman I
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():5-9. PubMed ID: 8916979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHEA, important source of sex steroids in men and even more in women.
    Labrie F
    Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Available medical choices for the management of menopause.
    Castelo-Branco C; Palacios S; Calaf J; Vázquez F; Lanchares JL
    Maturitas; 2005 Nov; 52 Suppl 1():S61-70. PubMed ID: 16213114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postmenopausal bone loss. Role of estrogens].
    Trémollières F; Pouilles JM; Ribot C
    Presse Med; 1992 May; 21(19):903-6. PubMed ID: 1386433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?
    Kanis JA
    Osteoporos Int; 1998; 8 Suppl 1():S51-6. PubMed ID: 9682799
    [No Abstract]   [Full Text] [Related]  

  • 15. Oestrogen replacement--a boon or a curse?
    Burger HG
    Aust Fam Physician; 1977 Feb; 6(2):99-104. PubMed ID: 871277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms.
    Mirkin S; Ryan KA; Chandran AB; Komm BS
    Maturitas; 2014 Jan; 77(1):24-31. PubMed ID: 24246155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide-heat shock protein axis in menopausal hot flushes: neglected metabolic issues of chronic inflammatory diseases associated with deranged heat shock response.
    Miragem AA; Homem de Bittencourt PI
    Hum Reprod Update; 2017 Sep; 23(5):600-628. PubMed ID: 28903474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Menopause and hormone replacement therapy].
    Tóth KS
    Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S; Komm BS
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of estrogens in pathogenesis of age-related disease in women of menopausal age.
    Ratiani L; Parkosadze G; Cheishvili M; Ormotsadze G; Sulakvelidze M; Sanikidze T
    Georgian Med News; 2012 Feb; (203):11-6. PubMed ID: 22466534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.